Nebenwirkungen · Synagis
Synagis 50 mg/0.5 ml solution for injection Synagis 100 mg/1 ml solution for injection · Abschnitt 4.8 · PDF-Seite 5
HOS-090199 · Präparat HOS-084025
Palivizumab treatment schedule and adverse reactions were monitored in a group of nearly 20,000 infants tracked through a patient compliance registry between 1998 and 2000. Of this group 1,250 enrolled infants had 6 injections, 183 infants had 7 injections, and 27 infants had either 8 or 9 injections. Adverse reactions observed in patients after a sixth or greater dose were similar in character and frequency to those after the initial 5 doses.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2023-10-11T08:14:00Z · SHA-256 80b341ab31afe95db5c42fa61205421fb02b06bd1c5fb252bf6a42f441c92dde · Passage 5f3b5be8abba69857e6198d180d065d9f2315c7fed74e3e10d6e0b16e69f7682 · Zeichen 3221–3668 im Abschnitt